Diffusion imaging in Huntington's disease: comprehensive review

Carlos Estevez-Fraga1, Rachael Scahill1, Geraint Rees2,3

  • 1Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.

Summary

Huntington's disease (HD) progression can be tracked using diffusion MRI, revealing white matter degeneration in premanifest stages. This technology aids in understanding neurodegeneration and evaluating treatment effects in clinical trials.